Literature DB >> 10447760

Both kinetic data and epitope mapping provide clues for understanding the anti-coagulant effect of five murine monoclonal antibodies to human beta2-glycoprotein I.

V Regnault1, J Arvieux, L Vallar, T Lecompte.   

Abstract

The interaction between five murine monoclonal antibodies (mAb) and beta2-glycoprotein I (beta2GPI) in the absence of phospholipids was studied using surface plasmon resonance-based biosensor technology. Two separate epitope regions were confirmed for the five mAb but epitopes of two mAb were shown to be overlapping but not identical. The characteristics of binding on both immobilized beta2GPI, using different chemistries of coupling to a dextran matrix and antibody surfaces prepared by two strategies of immobilization, were compared. Binding was strongly influenced by the orientation of the immobilized partner, and the five mAb showed heterogeneity in their binding to immobilized and soluble beta2GPI. The observed stoichiometries of mAb-beta2GPI complexes and the detailed analysis of the kinetics of the association and dissociation phases of the interactions with soluble and immobilized beta2GPI revealed differences in the dissociation rate constants, resulting in a 10-fold higher affinity for immobilized beta2GPI compared to soluble beta2GPI for four out of five mAb. This suggests bivalent binding of these mAb to immobilized beta2GPI. In addition, the kinetic data helped explain the differing anti-coagulant properties of these mAb.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10447760      PMCID: PMC2326858          DOI: 10.1046/j.1365-2567.1999.00780.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  29 in total

1.  Immobilization of proteins to a carboxymethyldextran-modified gold surface for biospecific interaction analysis in surface plasmon resonance sensors.

Authors:  B Johnsson; S Löfås; G Lindquist
Journal:  Anal Biochem       Date:  1991-11-01       Impact factor: 3.365

2.  Anticardiolipin antibodies (ACA) directed not to cardiolipin but to a plasma protein cofactor.

Authors:  M Galli; P Comfurius; C Maassen; H C Hemker; M H de Baets; P J van Breda-Vriesman; T Barbui; R F Zwaal; E M Bevers
Journal:  Lancet       Date:  1990-06-30       Impact factor: 79.321

3.  Heterogeneity of anticardiolipin antibodies defined by the anticardiolipin cofactor.

Authors:  E Matsuura; Y Igarashi; M Fujimoto; K Ichikawa; T Suzuki; T Sumida; T Yasuda; T Koike
Journal:  J Immunol       Date:  1992-06-15       Impact factor: 5.422

4.  Lupus-like anticoagulant properties of murine monoclonal antibodies to beta 2-glycoprotein I.

Authors:  J Arvieux; P Pouzol; B Roussel; M C Jacob; M G Colomb
Journal:  Br J Haematol       Date:  1992-08       Impact factor: 6.998

5.  Complete nucleotide and deduced amino acid sequence of human beta 2-glycoprotein I.

Authors:  A Steinkasserer; C Estaller; E H Weiss; R B Sim; A J Day
Journal:  Biochem J       Date:  1991-07-15       Impact factor: 3.857

6.  Complete amino acid sequence of human plasma beta 2-glycoprotein I.

Authors:  J Lozier; N Takahashi; F W Putnam
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

7.  Amino acid sequence and location of the disulfide bonds in bovine beta 2 glycoprotein I: the presence of five Sushi domains.

Authors:  H Kato; K Enjyoji
Journal:  Biochemistry       Date:  1991-12-17       Impact factor: 3.162

8.  Immunopurification of human beta2-glycorprotein I with a monoclonal antibody selected for its binding kinetics using a surface plasmon resonance biosensor.

Authors:  V Regnault; J Arvieux; L Vallar; T Lecompte
Journal:  J Immunol Methods       Date:  1998-02-01       Impact factor: 2.303

9.  Molecular definition of human beta 2-glycoprotein I (beta 2-GPI) by cDNA cloning and inter-species differences of beta 2-GPI in alternation of anticardiolipin binding.

Authors:  E Matsuura; M Igarashi; Y Igarashi; H Nagae; K Ichikawa; T Yasuda; T Koike
Journal:  Int Immunol       Date:  1991-12       Impact factor: 4.823

10.  Association of anti-beta 2 glycoprotein I antibodies with lupus-type circulating anticoagulant and thrombosis in systemic lupus erythematosus.

Authors:  J P Viard; Z Amoura; J F Bach
Journal:  Am J Med       Date:  1992-08       Impact factor: 4.965

View more
  1 in total

1.  Biotinylation of glycan chains in beta2 glycoprotein I induces dimerization of the molecule and its detection by the human autoimmune anti-cardiolipin antibody EY2C9.

Authors:  Arnaud Dupuy D'Angeac; Ilias Stefas; Hubert Graafland; Frédéric De Lamotte; Marcel Rucheton; Caroline Palais; Anna-Karin Eriksson; Priscille Bosc; Caroline Rosé; Robert Chicheportiche
Journal:  Biochem J       Date:  2006-01-01       Impact factor: 3.857

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.